CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2007-05-15): Liver stiffness tied to portal hypertension in cirrhosis

Clinical

Liver stiffness tied to portal hypertension in cirrhosis

Last Updated: 2007-05-15 16:04:17 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Liver stiffness is indicative of portal hypertension in patients with hepatitis C virus (HCV)-related cirrhosis, Italian researchers report in the May issue of Hepatology

"Measurement of liver stiffness by transient elastography," senior investigator Dr. Massimo Pinzani told Reuters Health, "is a rapid and non-invasive system able to identify cirrhotic patients with clinically significant and severe portal hypertension."

These are patients, he added, "urgently needing further investigation and particularly upper GI endoscopy for the detection of esophageal varices."

Dr. Pinzani of the University of Florence and colleagues evaluated the ability of transient elastography to predict portal hypertension in 61 patients with HCV-related chronic liver disease. Transient elastography is based on measurement of the velocity of an acoustic shear wave induced in liver tissue, which is directly related to liver stiffness.

A strong relationship was found between liver stiffness and hepatic venous pressure gradient (HVPG), a standard method for the assessment of portal pressure.

However, the excellent correlation observed at HVPG values below 10 or 12 mm Hg was not seen at values at or above these levels. In addition, liver stiffness measurement positively correlated with the presence of esophageal varices, although no correlation with their size was apparent.

Transient elastography, using the FibroScan (Echosens) device, continued Dr. Pinzani, "can be performed in outpatient clinics, requires a very short training, and is characterized by very low intra- and inter-observer variability."

In an accompanying editorial, Drs. Joseph K. Lim and Roberto J. Groszmann of Yale University School of Medicine, New Haven, Connecticut note this is one of a number of new and promising approaches.

However, they also say that "the data supporting its role in evaluating the consequences of portal hypertension remain unconvincing. Additional data in carefully designed studies will help define its appropriate role in clinical practice."

Hepatology 2007;45:1290-1297.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.